Cerebrovascular Disorder
9
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
Natural History of Stroke: Cause and Development
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.
Aneurysms and Carotid Artery Block in Newborns
Intervention in Informal Caregivers Who Care Older People After a Stroke: a Pilot Study in Northern Portugal
Magnetic Resonance Imaging Studies of Motor and Thought Processes
Brain Blood Flow Studies of Language and Memory